glp 1 journey meaning GLP-1 Your GLP-1 journey is unique,

Key advances Semaglutide reduces cardiovascular morbidity and all-cause mortality in people with obesity 1

While the type of GLP-1 RA formulation or duration of treatment did not affect gastric emptying (scintigraphy), it was significantly increased in obese patients with BMI 30 kg/m 2 ( p = 0.018)

Daily oral medication provides limited suppression that wears off between doses (especially if you miss a day or dont follow strict timing rules)

Key lifestyle investments during treatment include developing a sustainable eating pattern that does not rely on appetite suppression, building strength training habits that preserve and build lean mass, addressing emotional eating patterns through therapy or structured programs, establishing sleep hygiene that supports metabolic health, and managing stress through sustainable practices

Microdosing involves the off-label use of GLP-1 medications (semaglutide and tirzepatide) at much smaller doses than the standard recommended dose, such as: Consuming a fraction of a starter dose, such as 0.05 mg of Ozempic instead of 0.25 mg

This will support more informed, anticipatory, and patient-centered care in the emergency department